The causal association of higher BMI with hospitalisation for fungal infections was of a similar magnitude but was not significant (OR 1.48 [95%CI 0.73,3.00]), potentially due to the lower number of events for this outcome
Key Takeaways Oral semaglutide is a promising new weight loss medication, expected to be the first oral GLP-1 treatment for obesity, demonstrating significant efficacy in clinical trials with a potential weight loss of up to 15%
Nausea Often Happens During Dose Escalation Many people notice nausea when they first start the medication or when their dose increases
Pull it out, draw your dose with clean technique, and return it within a few minutes
People who take CONTRAVE must not use any type of opioid, including street drugs, prescription pain medicines, cough, cold, or diarrhea medicines that contain opioids, or opioid dependence treatments, for at least 7 to 10 days before starting CONTRAVE
(b) poor safety